

Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Olive
Therapeutic Area : Nutrition and Weight Loss
Study Phase : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Baxter Secures FDA Approval for Clinolipid in Neonates and Pediatrics
Details : Clinolipid is a mixed oil lipid emulsion providing essential fatty acids and calories in parenteral nutrition when oral or enteral nutrition isn’t viable.
Product Name : Clinolipid
Product Type : Undisclosed
Upfront Cash : Inapplicable
May 13, 2024
Lead Product(s) : Olive
Therapeutic Area : Nutrition and Weight Loss
Highest Development Status : Approved FDF
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Olive
Therapeutic Area : Endocrinology
Study Phase : Phase II
Sponsor : Andalusian Health Service | Universidad Pablo de Olavide
Deal Size : Inapplicable
Deal Type : Inapplicable
Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Diabetes Mellitus.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
September 11, 2023
Lead Product(s) : Olive
Therapeutic Area : Endocrinology
Highest Development Status : Phase II
Sponsor : Andalusian Health Service | Universidad Pablo de Olavide
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Olive
Therapeutic Area : Gastroenterology
Study Phase : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Stomatitis.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
December 02, 2022
Lead Product(s) : Olive
Therapeutic Area : Gastroenterology
Highest Development Status : Undisclosed
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Olive
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Undisclosed
Sponsor : Lumenis | Mucosa Innovations
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Female Urogenital Diseases.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
October 18, 2022
Lead Product(s) : Olive
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Undisclosed
Sponsor : Lumenis | Mucosa Innovations
Deal Size : Inapplicable
Deal Type : Inapplicable

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Study Phase : Phase II/ Phase III
Sponsor : Universidad de Granada
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Olive is a drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
July 19, 2022
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Highest Development Status : Phase II/ Phase III
Sponsor : Universidad de Granada
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Olive
Therapeutic Area : Pharmacology/Toxicology
Study Phase : Phase I
Sponsor : Baxter Healthcare Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable
Safely and Efficacy of ClinOleic-based Lipid Parenteral Nutrition
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Nutritional Supplement Toxicity.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 09, 2019
Lead Product(s) : Olive
Therapeutic Area : Pharmacology/Toxicology
Highest Development Status : Phase I
Sponsor : Baxter Healthcare Corporation
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Study Phase : Undisclosed
Sponsor : BASF
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of undefined medical condition.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
July 19, 2018
Lead Product(s) : Olive
Therapeutic Area : Undisclosed
Highest Development Status : Undisclosed
Sponsor : BASF
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Olive
Therapeutic Area : Musculoskeletal
Study Phase : Undisclosed
Sponsor : Institut National De La Recherche Agronomique | Centre de Recherche en Nutrition Humaine d'Auvergne
Deal Size : Inapplicable
Deal Type : Inapplicable
Olive Oil Polyphenols, Vitamin D, Docosahexaenoic Acid (DHA) and Locomotor Function (PolivD3)
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in clinical studies for the treatment of Bone Diseases, Metabolic.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
April 11, 2013
Lead Product(s) : Olive
Therapeutic Area : Musculoskeletal
Highest Development Status : Undisclosed
Sponsor : Institut National De La Recherche Agronomique | Centre de Recherche en Nutrition Humaine d'Auvergne
Deal Size : Inapplicable
Deal Type : Inapplicable

Lead Product(s) : Olive
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
AV2 Antiviral Spray Versus Placebo in Human Papillomavirus Cervix Infections
Details : Olive Oil is a Plant Extract/Herbal drug candidate, which is currently being evaluated in phase II clinical studies for the treatment of Papillomavirus Infections.
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
August 01, 2012
Lead Product(s) : Olive
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
